MedTrace Logo

Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients

NCT04361396 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2024-09-19

No results posted yet for this study

Summary

The purpose of this study is to determine whether the virus SARS-CoV-2, responsible for the disease COVID-19, is present in the abdominal cavity during emergency laparoscopic exploration in confirmed or suspected COVID-19 patients.

Conditions

  • Coronavirus Infection

Interventions

OTHER

Collection of samples

Only in enrolled patient : different samples will be taken at different times of the surgery (3 samples of pneumoperitoneum, 1 sample of peritoneal effusion or peritoneal lavage fluid and 1 sample of bile, in case of cholecystectomy.

Sponsors & Collaborators

  • Hôpital NOVO

    lead OTHER

Principal Investigators

  • Nelson Trelles · Hôpital NOVO

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-16
Primary Completion
2021-12-16
Completion
2022-01-18

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04361396 on ClinicalTrials.gov